For emerging markets worldwide, the average value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health and pharmaceuticals sector as of 2023 was a multiple of approximately 19.9x. Companies operating in the healthcare information & technology industry saw the highest valuation multiple with EV/EBITDA valued at 36.5x.
Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry
Characteristic
Jan '19
Jan '20
Jan '21
Jan '22
Jan '23
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Values are as of January each year.
A total of 1,796 companies were included in the calculation for 2023.
Enterprise value = Market value of equity + Market value of debt - Cash. EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT).
Emerging markets include; Anguilla, Antigua & Barbuda, Argentina, Azerbaijan, Bahamas, Bahrain, Bangladesh, Bermuda, Botswana, Brazil, British Virgin Islands, Bulgaria, Burkina Faso, Cambodia, Cameroon, Cayman Islands, Chile, China, Colombia, Costa Rica, Croatia, Curaçao, Dominican Republic, Ecuador, Egypt, Estonia, Falkland Islands, Gabon, Ghana, Greenland, Hong Kong, India, Indonesia, Israel, Ivory Coast, Jamaica, Jordan, Kazakhstan, Kenya, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lithuania, Macau, Macedonia, Malawi, Malaysia, Mali, Marshall Islands, Mauritius, Mexico, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Netherlands Antilles, Niger, Nigeria, Oman, Pakistan, Palestinian Authority, Panama, Papua New Guinea, Peru, Philippines, Qatar, Romania, Russia, Saint Lucia, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, Solomon Islands, South Africa, South Korea, Sri Lanka, Sudan, Taiwan, Tanzania, Thailand, Togo, Trinidad & Tobago, Tunisia, Turks & Caicos Islands, Uganda, Ukraine, United Arab Emirates, Uruguay, Vietnam, Zambia, Zimbabwe.
Figures for years 2019 to 2022 were previously published by the source.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2023). Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry [Graph]. In Statista. Retrieved August 24, 2024, from https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry." Chart. January 5, 2023. Statista. Accessed August 24, 2024. https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business. (2023). Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry. Statista. Statista Inc.. Accessed: August 24, 2024. https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health and Pharmaceuticals Sector in Emerging Markets Worldwide from 2019 to 2023, by Industry." Statista, Statista Inc., 5 Jan 2023, https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry Statista, https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/ (last visited August 24, 2024)
Average EV/EBITDA multiples in the health and pharmaceuticals sector in emerging markets worldwide from 2019 to 2023, by industry [Graph], Leonard N. Stern School of Business, January 5, 2023. [Online]. Available: https://www.statista.com/statistics/1030501/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-emerging-markets/